Does TINZAPARIN Cause Hepatic cytolysis? 34 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Hepatic cytolysis have been filed in association with TINZAPARIN. This represents 2.0% of all adverse event reports for TINZAPARIN.
34
Reports of Hepatic cytolysis with TINZAPARIN
2.0%
of all TINZAPARIN reports
0
Deaths
17
Hospitalizations
How Dangerous Is Hepatic cytolysis From TINZAPARIN?
Of the 34 reports, 17 (50.0%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TINZAPARIN. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does TINZAPARIN Cause?
Acute kidney injury (135)
Anaemia (118)
Off label use (110)
Maternal exposure during pregnancy (108)
Thrombocytopenia (86)
Drug ineffective (82)
Toxic epidermal necrolysis (80)
Hepatocellular injury (70)
Premature baby (70)
Cholestasis (67)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which TINZAPARIN Alternatives Have Lower Hepatic cytolysis Risk?
TINZAPARIN vs TIOCONAZOLE
TINZAPARIN vs TIOPRONIN
TINZAPARIN vs TIOTROPIUM
TINZAPARIN vs TIPIRACIL\TRIFLURIDINE
TINZAPARIN vs TIPRANAVIR